IceCure Medical (ICCM) Cash & Current Investments (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Cash & Current Investments data on file, last reported at $8.1 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $8.1 million, up 34.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.1 million (up 34.35% YoY), and the FY2025 annual result was $8.9 million, up 17.62% from the prior year.
• Cash & Current Investments eased to $8.1 million in Q1 2026 per ICCM's latest filing, from $8.9 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $321.6 million in Q4 2022 and troughed at $4.1 million in Q3 2023.
• A 5-year average of $28.9 million and a median of $10.7 million in 2024 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments surged 1155.3% in 2022, then plunged 96.56% in 2023.
• A 5-year view of Cash & Current Investments shows it stood at $321.6 million in 2022, then sank by 96.56% to $11.1 million in 2023, then tumbled by 31.62% to $7.6 million in 2024, then rose by 17.62% to $8.9 million in 2025, then retreated by 8.79% to $8.1 million in 2026.
• Business Quant data shows ICCM's Cash & Current Investments at $8.1 million in Q1 2026, $8.9 million in Q4 2025, and $10.0 million in Q3 2025.